Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 6
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP22F6749 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-08-18 | 2022-08-30 | 325412 | 8509324197!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6743 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-08-18 | 2022-08-30 | 325412 | 8509324137!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6113 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-07-18 | 2022-07-26 | 325412 | 8509243570!ADENOVIRUS TYPE 4 A |
| SPE2DP22F6112 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-07-18 | 2022-07-26 | 325412 | 8509243441!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5153 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-06-14 | 2022-06-28 | 325412 | 8509165125!ADENOVIRUS TYPE 4 A |
| SPE2DP22F5146 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-06-15 | 2022-06-28 | 325412 | 8509164321!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4654 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-05-17 | 2022-05-24 | 325412 | 8509105232!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4651 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-05-17 | 2022-05-24 | 325412 | 8509105123!ADENOVIRUS TYPE 4 A |
| SPE2DP22F4077 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-04-19 | 2022-04-26 | 325412 | 8509034793!ADENOVIRUS TYPE 4 A |
| SPE2DP22F3548 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-03-22 | 2022-03-29 | 325412 | 8508961384!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2563 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-02-10 | 2022-03-01 | 325412 | 8508862259!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2118 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $587.3K | 2022-01-18 | 2022-01-25 | 325412 | 8508811981!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6145 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-09-09 | 2021-09-28 | 325412 | 8508509768!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6143 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-09-09 | 2021-09-28 | 325412 | 8508509767!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6139 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-09-09 | 2021-09-28 | 325412 | 8508509760!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5499 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-08-11 | 2021-08-24 | 325412 | 8508433261!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4963 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-07-13 | 2021-07-20 | 325412 | 8508354363!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4962 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-07-13 | 2021-07-20 | 325412 | 8508354228!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4960 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-07-13 | 2021-07-20 | 325412 | 8508354097!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4959 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-07-13 | 2021-07-20 | 325412 | 8508354096!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4302 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-06-08 | 2021-06-22 | 325412 | 8508275918!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4297 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-06-08 | 2021-06-22 | 325412 | 8508275806!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3775 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-05-06 | 2021-05-25 | 325412 | 8508191715!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3211 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-04-06 | 2021-04-27 | 325412 | 8508113867!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3208 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-04-06 | 2021-04-27 | 325412 | 8508113864!ADENOVIRUS TYPE 4 A |